This is a past event. To see the list of our current events, please click  HERE

Jason Adler

Managing Member
Gotham Green Partners

Jason is a director of The Cronos Group (MJN.V), a geographically diversified and vertically integrated cannabis company that operates within Health Canada's Access to Cannabis for Medical Purposes Regulations. He is also the Founder and Managing Partner of Gotham Green Partners, a cannabis focused Private Equity Fund. Prior to founding Gotham Green, Jason was the co-founder and CEO of Alphabet Management, LLC, a New York based volatility fund, that focused on identifying mispriced assets across various industries, asset classes and geographies. Jason also founded Geronimo, LLC, an AMEX member broker dealer that made markets in equity options, and he began his career as a market maker at G&a ... (view full description)

Vivien Azer

Managing Director
Cowen and Company

Vivien Azer is a managing director and senior research analyst specializing in beverages, tobacco, and cannabis sectors. Vivien is the first senior Wall Street analyst to cover the emerging cannabis sector, resulting in notable global press coverage across media outlets such as CNBC, The Wall Street Journal, The Economist, Barron’s and Forbes.  Vivien’s coverage of the tobacco and cannabis sectors earned her industry accolades including a spot on Institutional Investor’s All-America Research Team on several occasions. She was also named to MJBiz Daily’s list of “20 Women to Watch in 2019” and selected by Business Insider as a “Rising Star of Marijuana Investing.” Viv ... (view full description)

Jake Bergmann

Founder & CEO
Surterra Holdings

Jake is the Founder and Chief Executive Officer of Surterra Holdings, Inc.   Since founding Surterra in early 2014, Jake has lead the company in raising more than $50 million of capital, securing 1 of the original 5 vertically integrated licenses in the State of Florida and 1 of 3 vertically integrated licenses in the State of Texas.  After winning its first license in November 2015, Jake also led Surterra’s rapid expansion from 7 to nearly 100 employees and from 6,000 square feet of cultivation space to more than 300,000 square feet of fully permitted production space, among the largest operations in North America.   Prior to Surterra, Jake began ... (view full description)

Debra Borchardt

CEO & Editor-in-Chief
Green Market Report

Debra Borchardt is the CEO and Editor-in-Chief of the cannabis financial news website Green Market Report. She began her career in the securities industry where she held several securities licenses. Debra left her last position as a Vice President at Bear Stearns to earn her Masters Degree in Business and Economic Reporting from New York University. At that point she embarked on a career as a financial journalist and spent eight years at TheStreet.com working daily with Jim Cramer. As a senior producer and reporter at TheStreet.com, Debra honed her skills as a journalist earning an award from ASPBE.org (American Society of Business Publication Editors)  in 2014 for Best Video - News, “Guess ... (view full description)

Scot Crow

Member & Practice Department Manager
Dickinson Wright PLLC

Scot has extensive experience in corporate, mergers and acquisitions and tax law. His clients rely on him to advise them with respect to their complex financial transactions as well as serving as their outside general counsel. Scot provides proactive advice with respect to sensitive management matters, litigation management, day to day transactional needs and objective assessments for the development of successful business strategies. Scot has served as lead counsel in numerous mergers and acquisitions, private equity investments, private offerings, venture capital financings, mezzanine debt offerings, divestures and other related transactions, with an emphasis in the following business sect ... (view full description)

Vikas Desai

Partner
WelCan Capital

Vikas Desai is a co-founder and partner at WelCan Capital, a venture capital firm focused on impact investing in the cannabis industry. WelCan invests in high-impact, foundational companies across early-stage, plant touching and ancillary businesses. Prior to WelCan, Vikas was a private equity investor at Oaktree Capital Management, a $100+ billion alternative asset manager, where he focused on opportunistic real estate investments and completed over $2+ billion in transactions. Prior to Oaktree, Vikas began his career at Morgan Stanley as an investment banking analyst, focusing on real estate M&A and capital markets. Vikas has also personally invested in multiple technology companies an ... (view full description)

Arnaud Dumas de Rauly

Chief Executive Officer
The Blinc Group

Arnaud is currently the Co-founder and CEO of The Blinc Group, a company founded to innovate, manufacture and distribute safe, consistent vaping products. Arnaud leads and evaluates operations of the company through international marketing, communication and public relations. Arnaud also serves as the Chair of the ISO Standards Committee on Vapor Products and the CEN Standards Committee on Vapor Products.

Nic Easley

CEO & Managing Director
Multiverse Capital

Nic Easley is a globally recognized cannabis industry expert and a sought-after writer, panelist, and keynote speaker for many top conferences and publications. He is the CEO and Managing Director of Multiverse Capital™, a cannabis venture firm, and the founder and CEO of 3C Consulting, LLC, the leading global strategic cannabis consulting firm. Nic and his team have worked in 16 countries, 34 U.S. States, and two territories assisting nearly 500 cannabis companies across all sectors of the industry. He is known for his passionate commitment to introducing demonstrated best practices from other industries into the cannabis space. His industry-leading track record of building stro ... (view full description)

Ruth Epstein

President, CFO & Director
Tuscan Holdings

Ruth Epstein is the co-founder of BGP Advisors, a California-based boutique business and financial advisory firm, providing capital raising and strategic and marketing advisory services to companies in the rapidly evolving legal cannabis industry. She also serves as CFO for  Treez, Inc. a leading SaaS provider of point of sale/retail management solutions to dispensaries. Ruth is also an active angel investor in the legal cannabis industry. She holds an MBA from Harvard Business School and spent ten years in investment banking with Goldman, Sachs & Co. in New York and San Francisco, where she was extensively involved in executing both public and private equity and debt offerings and M& ... (view full description)

Hadley Ford

CEO & Director
iAnthus

Hadley Ford is a healthcare and technology industry veteran with more than 20 years of experience as both an operating executive and investment banker. Mr. Ford has extensive experience in all operational facets of managing a large, world-class patient-centric healthcare operation. From 2005 to 2013, Mr. Ford was the co-founder and CEO of ProCure Treatment Centers, Inc., developer and operator of full-service proton therapy centers for the treatment of cancer. From ProCure’s inception, Mr. Ford grew the company to over 300 employees and $100 million of annual revenue. Prior to ProCure, Mr. Ford spent fourteen years on Wall Street with First Boston, Bank of America and Goldman Sachs, where he ... (view full description)

Al Foreman

CIO
Tuatara Capital LP

Al Foreman has over 20 years of professional experience in private equity, corporate finance, and financial technology, and a broad transaction history that includes the origination, structuring, and execution of debt, equity, and mergers and acquisitions transactions globally. Mr. Foreman is currently a Partner and the Chief Investment Officer of Tuatara Capital, L.P. a cannabis-focused alternative investment manager.  In this role Al is responsible for formulating Tuatara’s macro investment strategy and for the structuring and oversight of portfolio investments. Prior to co-founding Tuatara in 2014, Al was a Managing Director with Highbridge Principal Strategies, LLC, a $35 billion a ... (view full description)

Matt Ginder

Senior Counsel
Greenspoon Marder

Matthew Ginder is senior counsel in the Cannabis Law practice group at Greenspoon Marder.  Mr. Ginder represents various cannabis related businesses assisting in many areas of the industry, including licensing, regulatory and compliance, and business transactions.  He also represents individuals and entities interested in investing in state legal cannabis businesses.  Mr. Ginder co-founded and manages a nonprofit organization called the Organization for Safe Cannabis Regulation (OSCR), which advocates on behalf of cannabis related businesses in Florida.  He is frequently sought after to comment on the medical marijuana market and has been quoted extensively in several well-known publications ... (view full description)

Scott Greiper

President
Viridian Capital Advisors, LLC

Mr. Greiper has had a highly successful 30-year career on Wall Street and in his own businesses, with a focus on helping to back and build emerging growth companies. He is the Founder and President of Viridian Capital Advisors, LLC, a financial and strategic advisory firm dedicated to the medicinal and legal cannabis market. Viridian provides market intelligence, investment banking, and corporate development services to emerging growth companies in the cannabis sector. Its banking practice, through broker-dealer Pickwick Capital Partners, LLC (Member FINRA/SIPC), provides capital and M&A to fund the growth of Viridian's clients, while its advisory practice helps to position and bui ... (view full description)

Robert Groesbeck

Co-CEO
Planet 13 Holdings, Inc.

Robert Groesbeck has been in the Las Vegas area for the majority of his life. He has been a long-time entrepreneur, starting and/or assisting in the creation of a number of businesses. Mr. Groesbeck was designated as one of the top forty Southern Nevada Business Executives under the age of forty, on the basis of his professional achievement and community service by the Las Vegas Business Press. Mr. Groesbeck has extensive experience in the legal field. He has practiced law for over 25 years, and has knowledge about multiple aspects of the law. He also served as the Mayor of the City of Henderson from 1993 to 1997. Mr. Groesbeck earned his B.S. in Criminal Justice from the University of ... (view full description)

Michael Gruber

Managing Partner
Salveo Capital

Michael Gruber is a Managing Partner of Salveo Capital, a private equity fund focused on the cannabis industry.   Mr. Gruber prior to co-founding Salveo Capital,  had been active in advising operators and families in both raising capital and merging/acquiring assets within the cannabis industry, and had made several direct investments within the sector. Mr. Gruber has over 20 years of experience working with early stage investments, particularly in the information technology, financial services, energy, and agriculture sectors. Mr. Gruber is a founding Partner of Independence Equity, a committed venture capital fund focused on investments focused on improving resource utilization ... (view full description)

Catherine Hastings

CFO
Innovative Industrial Properties

Catherine (Cat) serves as CFO, Chief Accounting Officer and Treasurer of Innovative Industrial Properties, Inc (IIPR) – an NYSE- traded REIT.  IIPR targets medical-use cannabis facilities for acquisition, including sale-leaseback transactions, with tenants that are licensed growers under long-term triple net leases.    Prior to joining IIPR, Cat served as vice president, internal audit of BioMed Realty Trust, Inc. (formerly NYSE: BMR), a REIT specializing in acquiring, leasing, developing and managing laboratory and office space for the life science industry.  She also was director of financial accounting and audit for The Corky McMillin Companies, a privately held real es ... (view full description)

Steven Hawkins

Executive Director
Marijuana Policy Project

Steven Hawkins is Executive Director of the Marijuana Policy Project, the most effective organization in the United States advancing legalization of cannabis for adult use and medical treatment.  He has held a number of leadership positions within the nonprofit sector, including Executive Vice President of the NAACP, Executive Director of Amnesty International USA, President of the Coalition for Public Safety and Executive Director of the National Coalition to Abolish the Death Penalty.  He began is his career as a civil rights attorney, largely representing persons facing the death penalty throughout the country. He is a graduate of Harvard College and NYU School of Law.

John Kagia

Chief Knowledge Officer
New Frontier Data

John Kagia is considered to be one the pioneering thought leaders in the cannabis industry. He has developed market leading forecasts for the growth of the industry, uncovered groundbreaking research into the cannabis consumer, and led the first-of-its-kind analysis of global cannabis demand. Kagia is a sought-after speaker and his presentations have been regarded as some of the most thought provoking and rich updates on key trends shaping the industry.  He is widely quoted in countless publications (NYT, WaPo, CNN, Fortune, BBC, ABC) and has played an active role in advising lawmakers and regulators looking to establish and regulate cannabis industries.  Leveraging ... (view full description)

Rob Kampia

Executive Director
Marijuana Leadership Campaign

Rob previously co-founded the Marijuana Policy Project in 1995 and served as its executive director for 23 years, leaving MPP in 2017 to found the Marijuana Leadership Campaign, which is based in Austin and Washington, D.C. Rob grew up in the suburbs of Philadelphia in Harleysville, Pennsylvania. In 1986, he graduated as valedictorian of his class at Souderton Area High School, and in 1993 he graduated with honors from Penn State University with a bachelor’s degree in Engineering Science and a minor in English. In the middle of his seven-year tenure at Penn State where he had a full scholarship, he served three months in a county prison near State College after being ... (view full description)

Darren Karasiuk

EVP, Adult Usage, Global
Aurora Cannabis Inc.

Matt Karnes

Founder & Managing Partner
GreenWave Advisors

Matthew (Matt) Karnes has over 20 years of diverse finance and accounting experience. Prior to founding GreenWave Advisors LLC in 2014, Matt worked in equity research focusing on the Radio Broadcasting and Cable Television industries for First Union Securities. Matt also covered Satellite Communication at SG Cowen and in addition, worked with the top ranked Consumer Internet analyst at Bear Stearns & Co – this team was consistently recognized by the Institutional Investor’s “All America Research Team”.  As a sellside equity analyst, Matt authored and co-authored numerous emerging industry research reports including such names as Google, Sirius, XM Satellite Radio, DIRECTV and EchoStar Co ... (view full description)

Steve Klein

Chairman & Chief Strategist
Flowr

Steve Klein began his career as a corporate tax attorney at Skadden Arps in New York before leaving in 1992 to co-found Apple Core Holdings, a private investment firm located in midtown New York.  Over the past five years, Steve has invested in several cannabis companies and, two years ago, co-founded Flowr with Tom Flow, who previously co-founded Medreleaf.   Steve and his group have led every round of Flowr’s funding to date. Apple Core’s investments include hotels in Manhattan, large event spaces in New York City, technology venture investments in the United States and Israel, and seed investments in hedge funds and venture funds.  Steve's diverse background also includes producing both t ... (view full description)

Kris Krane

Trustee
New Jersey Cannabis Industry Association (NJCIA)

Kris Krane serves as a Principal at 4Front Ventures, an investment and operations company dedicated to professionalizing the cannabis industry. 4Front's subsidiary Mission Partners operates dispensaries, cultivation and production facilities across the United States.  Its sister company 4Front Advisors has experienced unparalleled success in helping clients navigate the complex regulatory process necessary to obtain medical cannabis business permits in state regulated markets, assisting clients in procuring over 50 dispensary and cultivation licenses in seven states in highly competitive application processes.  Prior to forming 4Front, Kris served as Director of Client Services for CannBe, w ... (view full description)

Abner Kurtin

CEO & Founder
AWH

Abner Kurtin is the Founder of Ascend. He has been managing opportunity capital for over 20 years. Prior to Ascend, Abner was the Founder of K Capital Partners a multi billion dollar hedge fund, Ca2 Group a high end real estate development firm in Massachusetts and JM10 Partners Fund. He started his career at The Baupost Group and served as a member of the Presidents Council of Mass General Hospital and Chairman of the Hill House. Abner graduated Harvard Business School and completed his BA at Tufts University.

Chris Leavy

Partner
Shire Capital Advisors

Chris Leavy is a partner with Shire Capital Advisors, where he leads an investment group that has deployed over $100 million into private transactions in the cannabis industry. Chris is currently on the board of Ascend Wellness Holdings and the advisory board of Norcal Cannabis Company. He was named 20 People to Watch by Marijuana Business Magazine and was formerly the Co-Chairman of the Investment Committee for MedMen Opportunity Fund II.   Chris brings over two decades of experience in asset management with senior roles at Morgan Stanley, OppenheimerFunds and BlackRock. As a Managing Director at BlackRock, Chris oversaw $115 billion of fundamental equities and was a member of t ... (view full description)

Adam Levin

CEO
High Times

Mr. Adam E Levin is the Chief Executive Officer of the High Times Group, and the founder of Hightimes Holding Corp. He has served as HTHC's Chairman and Chief Executive Officer since its inception, where he led the acquisition of the Trans-High Corporation in March 2017. Mr. Levin has spent the past 15+ years leading Internet-based technology and e-commerce companies, and leading the acquisitions of a number of businesses such as Pride Media, Bebo.com, and Boxlight (NASDAQ: BOXL). Mr. Levin is the Founder of Oreva Capital, and previously served as Managing Director at Criterion Capital Partners. Mr. Levin has been a featured speaker at many events, such as CES, MIPTV, and MONY Conference, an ... (view full description)

Neal Levine

CEO
Cannabis Trade Federation

Neal Levine is an entrepreneur, nationally recognized expert in both cannabis policy and ballot initiative/independent expenditure campaigns, and a leading national advocate for the cannabis industry. Neal co-founded and serves as the CEO of the Cannabis Trade Federation (CTF), which is a national coalition of cannabis-related businesses that represent all aspects of the industry including cultivators, dispensaries, wholesalers, distributors, and ancillary businesses.   Prior to forming CTF, Neal served as Senior Vice President of Government Affairs at LivWell Enlightened Health, one of the largest employers in the cannabis industry. In this role Neal led the company’s government ... (view full description)

Steve Malloy

CEO
PharmaRolly Holdings BV

Mr. Malloy is the founder and CEO of PharmaRolly Holdings B.V.  PharmaRolly has obtained Federal approval to cultivate medical cannabis and is actively developing a facility in Europe for export. The facility has over 1 million square feet of land for greenhouse grow together with an over 40,000 sq feet building for fully indoor, cultivation and extraction of medical THC & CBD products in accordance with GMP standards.  PharmaRolly expects to commence cultivation operations shortly.
 

Kendra Mark

CEO
2Rise Naturals


Kendra is the Founder and CEO of 2Rise Naturals, a startup CBD company based in Arizona. She specializes in CBD education, product development/formulation, and supply chain for the CBD and nutraceutical industries. Prior to starting 2Rise Naturals, Kendra was a formulations consultant for nutraceutical brands. Her passion for educating the consumer to understand ingredients in products led her to creating her own company and consulting for others willing to adopt clean ingredient panels.

Diana Martinez, MD

Professor of Psychiatry
Columbia University Medical Center

Dr. Diana Martinez is psychiatrist and Professor of Psychiatry at the Columbia University Medical Center. Her research career has focused on imaging the neuroscience and pharmacology of addiction. More recently, her research has moved into the use of cannabis for refractory disorders, particularly neuropathy caused by chemotherapy and improving the tolerability of radiation in cancer patients. The incentive for this has been the promising pharmacology of cannabis combined with the need for definitive clinical trails in this particular field.
 

Jim McCormick

CFO
Kush Bottles, Inc.

Matt Murphy

VP, Compliance
Khiron Life Sciences

Mr. Murphy is an executive leader with broad based domestic and international expertise in both the federal and private sectors. As a Career Special Agent (25 years) with the DEA, he served in a multitude of positions prior to founding the Pharma Compliance Group (PCG). Mr. Murphy is an internationally recognized security expert in the fields of drug law enforcement, risk assessment and system development, regulatory compliance, and training. Mr. Murphy will support the Company by implementing closed loop systems to prevent product diversion and to enhance protocols across Khiron's plant to patient value chain.

Stephen Murphy

Co-Founder & Group Managing Director
ECH

Stephen is Co-Founder and Group Managing Director of ECH an unrivalled group of companies at the forefront of the medical cannabis industry. As a cannabis specialist focused on developing the legal European cannabis industry, Stephen is also the co-founder of Prohibition Partners and of Cannabis Europa. With a background in technology, digital media and corporate finance, Stephen works with investors, entrepreneurs and regulators to identify, qualify and maximise the opportunities in this emerging frontier.
 

Chris Naprawa

President
Khiron Life Sciences

Mr. Naprawa brings extensive institutional capital markets experience to the Company. Prior to joining Khiron, Mr. Naprawa was Partner at Sprott Capital Partners, Head of Equity Sales at Macquarie Canada, Head of Equity Sales and Trading at Dundee Securities, and Managing Director at Primary Capital. He was also previously founder and CEO of Startcast Solutions, a company successfully sold to a large telecommunications company. Mr. Naprawa holds a Bachelor of Arts from Queen's University.

Jaimie Nawaday

Partner
Kelley Drye & Warren LLP

Jaimie Nawaday recently joined Kelley Drye after seven years as an Assistant U.S. Attorney (AUSA) for the Southern District of New York.  She focuses her practice on government investigations, white collar defense and civil litigation. As a former federal prosecutor, Jaimie draws on her unique insights into the U.S. Department of Justice perspective to provide counsel to cannabis businesses, investors and individuals. She also defends individuals who face federal criminal charges related to marijuana.  She has repeatedly appeared on MSNBC to explain and comment on developing issues in federal criminal law. Jaimie served in both the Civil and Criminal Divisions in the Southern Dis ... (view full description)

Emily Paxhia

Managing Director
Poseidon

Emily Paxhia is a co-founder and Managing Director of Poseidon. Emily has reviewed thousands of companies in the cannabis industry and has worked with countless founders in many capacities ranging from their pitch preparation, go-to-market strategies/product launches to business operations. She holds seats on the boards of directors for portfolio companies and participates as an advisor to multiple teams. Emily also serves on the Board of MTech Acquisition Corp. Emily is very active in the investment decision making and ongoing investment oversight processes working closely with her partners to source investment opportunities,  create meaningful deal structures and to ensure that ... (view full description)

Amy Peckham

CEO
Etain, LLC

Amy K. Peckham (CEO) is charged overseeing Etain, LLC  which is New York's only Women Owned and Family operated licensed Medical Marijuana Registered Organization.  In addition to overseeing the corporate mission for expansion to other markets, Amy specifically focuses on day-to-day concerns for Community Relations and Marketing. Ms. Peckham attended Catholic University in Washington, DC, and received her bachelor' s degree from Iona College, in New Rochelle, New York. Her extensive experience includes 15 years as a paralegal, and holding Corporate Secretary and Management Advisor responsibilities in Peckham Family Holdings, Inc., also a family-owned construction material company operating t ... (view full description)

Tahira Rehmatullah

Partner
Big Tent Ventures

Tahira Rehmatullah is President of T3 Ventures Advisory, Partner of Big Tent Ventures and Ceylon Solutions, and member of the board of directors for Akerna Corp. From brand building to hedge funds, Tahira has previously held positions at Hypur Ventures, MTech Acquisition Corp., Marley Natural, Privateer Holdings, City First Enterprises, Perry Capital, and Ernst & Young. She is an investor and advisor to numerous cannabis businesses and entrepreneurs, including the advisory board of The Initiative and the Last Prisoner Project, and is dedicated to developing female and minority leadership in the industry. Tahira earned her MBA from the Yale School of Management and B.S. in Finance from Th ... (view full description)

George Rogers

CEO
Wexler | Walker

George guides government affairs strategy and works with a range of corporate, trade association, and coalition clients to address legislative and regulatory issues. George served as Oversight "Czar" for the Republican Minority and prior to that as an Oversight Committee counsel. He has presented on effective crisis management before the Civil Justice Working Group, which representing many of the largest U.S. companies on tort-related matters. With deep policy expertise and expert procedural skills, George specializes in outmaneuvering his clients’ opposition. ​ With more than 13 years on Capitol Hill, George has close relationships with Republican leadership in both the House and Sena ... (view full description)

Peter Rosenberg

Partner
Merida Capital Partners

Peter Rosenberg is a partner and member of the Investment Committee at Merida Capital Partners, a New York based private equity fund focused on investing in the cannabis industry.  Peter has 30 years of experience in the financial services industry, where he has focused on leveraged finance, capital markets, strategic advisory, private equity and asset management. Throughout his career, he has executed capital raising, mergers and acquisitions, and restructuring transactions.  Before joining Merida, Peter was a Managing Director at Duff & Phelps as a Mergers and Acquisitions investment banker specializing in the Consumer and Retail sectors.  Previously, Peter was a Managing Director with ... (view full description)

Jennifer Sanders

Founder & CEO
CNS Equity Partners

With CNS Equity Partners and AURA Venture Funds, Jennifer leverages her expertise in the alternative agriculture and holistic health industries as a corporate consultant for institutional firms and investments.   As a  founder of CNS Equity Partners, a virtue-based private equity firm, she launched the nation’s first holistic health and cannabis herbal retailer. The fully integrated retailer, The Green Heart, is actively franchising  across the United States. A Harvard University Business School graduate, Jennifer specializes in international investment regulatory compliance and enterprise risk management with over 15 years of experience in leadership and business management. She has t ... (view full description)

Diane J. Savino

New York State Senator
The New York State Senate

New York State Senator Diane J. Savino (Democrat, Independent, Staten Island-Brooklyn) was born and raised in Astoria, Queens and was educated at Most Precious Blood Elementary School and Dominican Commercial High School.  She received her Bachelor’s Degree in Psychology with a minor in Sociology from St. John’s University and has a degree in Industrial and Labor Relations from Cornell University.   Diane Savino has dedicated her entire professional career towards improving the lives of working families. She began her career in public service as a caseworker for New York City’s Child Welfare Administration, providing direct assistance to abused and neglected children.    ... (view full description)

Adrian Sedlin

CEO
Canndescent

A lifelong entrepreneur, Adrian Sedlin builds brands and cash flow businesses from $0-$150MM in sales.Over his 25 year career, Mr. Sedlin has raised over $100MM in capital, created 5 successful exits, and thrived in diverse industries including B2B ecommerce, B2G SaaS, direct response, and consumer packaged goods.   Co-founding his first company at age 21, Mr. Sedlin served as its CEO and sold the business to Student Advantage (NASDAQ; STAD).Following this early career success, Mr. Sedlin served as a C-Suite executive in companies such as Credit2B (EVP; sold to S&P in 2001), Bargain Network (COO; Sold to Vertrue in 2004) and CrimeReports (Acting CEO; sold to Motorola in 2014) ... (view full description)

Timothy Seymour

Partner
Seymour Asset Management

Tim Seymour is founder and Chief Investment Officer of Seymour Asset Management (SAM).  SAM provides both asset management and wealth management services for its clients, including direct investment and allocation to private equity and alternative assets.  Tim has over 22 years of investment experience as a portfolio manager, allocator, and capital markets professional across multiple asset classes.  Tim is a recognized voice within the investment community as a trader and market strategist on CNBC.  For the past decade, Tim has been a primary investor voice on Fast Money.  Tim is often cited as one of top finance professionals on Twitter, including The Wall Street Journal’s “Top T ... (view full description)

Brian Sheng

CEO
Asia Horizon Group

Brian is the CEO of Asia Horizon Group. Asia Horizon is a US based private-equity holding company focused on the Asian hemp and cannabis industry.  Asia Horizon is the first North American company to acquire a license in China, and is looking to build and execute opportunistic investments into hemp assets across Asia. Prior to founding Asia Horizon, Brian Sheng was a General Partner with Arcview Ventures where he spearheaded the firm's international cannabis and hemp strategy.  Prior to Arcview, Brian was the co-founder of Fresh VC, a leading early stage venture capital fund focused on investments in frontier technologies between U.S and China.  At Fresh, Brian led the investments i ... (view full description)

Eric Stevens

Deputy Executive Director
Florida for Care

Eric Stevens helped launch Florida’s Medical Marijuana Yes on 2 campaign with United for Care in 2013 with John Morgan and Ben Pollara. He served as the Campaign’s Finance Director from 2013-2016 and worked on both the 2014 campaign and the 2016 campaign in Florida. The 2016 campaign passed with the highest margin of any medical marijuana question in any state ever at 71%.   He now serves as the Deputy Executive Director of Florida for Care, a non-profit(c)(4) membership based organization made up of the majority of those involved in Amendment 2. Florida for Care focuses on lobbying and educating elected officials and continuing to enact smart laws for Florida’s medical marijuana ... (view full description)

Sean Stiefel

Principal
Navy Capital

Sean Stiefel founded Navy Capital in 2014, where he manages a long/short portfolio focused on the Global Cannabis Sector. The Navy Capital Green Fund is the first US based Long/Short Public Equity Fund dedicated to Cannabis investing. Prior to founding Navy Capital, Mr. Stiefel was a research analyst and trader for Northwoods Capital Management Partners, a global long/short fund with a fundamental value and special situations investment strategy. Mr. Stiefel had previously served as an associate within an equity long/short fund at Millennium Partners, and he began his career as an equities trading analyst for Barclays Capital. He is a graduate of the University of Southern California&rsqu ... (view full description)

Micah Tapman

Managing Director
Canopy

Micah is a veteran of both the U.S. Marine Corps and the Fortune 500 world with an MBA and B.S. in computers. As a serial entrepreneur and venture capitalist he combines a deep understanding of technology with a focus on business strategy. His time in the Corps provided an outstanding leadership foundation, which melded with business training at SAIC and in graduate school to create a dynamic leader with the ability to motivate and empower those around him. Transitioning from a career in cybersecurity to the world of cannabis allowed Micah to focus more on the strategic aspects of business, identify and assist outstanding new businesses, and apply his portfolio management skills ... (view full description)

David Traylor

Sr Managing Director
Golden Eagle Partners

David Traylor is Senior Managing Director at Golden Eagle Partners, a firm he founded in 2012 to advise life science companies. After advising on various transactions in the life science, he took an interest in the cannabis sector and joined Surna, Inc. (OTC:SRNA) as Chief Business Officer in 2014.  After close to a year stint at Surna, David re-founded Golden Eagle Partners to provide his knowledge to companies across the cannabis sector. Before Golden Eagle Partners, David led the Life Science group at Headwaters MB, a leading boutique investment bank.   Before Headwaters, David served as a Senior Vice President at Caris & Company where he was focused on biopharmaceuticals. ... (view full description)

Smoke Wallin

President
Vertical

Smoke Wallin is a highly accomplished CEO, Entrepreneur, thought leader and board member with more than 25 years of success across the consumer products, alcohol beverage, distribution and technology industries. His broad areas of expertise include start-ups, branding, marketing innovation, distribution, transformational leadership, sales and business growth. He has extensive experience in regulated industries at the local, state and federal level. After studying the legal medical cannabis industry and recognizing the eventual convergence between legal cannabis and the alcohol beverage industry, Smoke sought out the right company to back with the right team and best opportunity t ... (view full description)

Chris Walsh

President
Marijuana Business Daily

Chris served as the founding editor of Marijuana Business Daily during the company’s launch in 2011, becoming the first journalist in the United States to focus exclusively on covering the business of cannabis. He now leads the company’s entire editorial and research team and oversees content-related strategic development initiatives. Chris has been quoted as one of America’s foremost cannabis industry analysts by dozens of media outlets, including Harvard Business Review, NPR, CNBC and the New York Times. He has an MBA and previously worked for more than a decade as a business reporter and editor at daily newspapers.

Tom Zuber

Managing Partner
Zuber Lawler

Tom Zuber is a founder and the Managing Partner of Zuber Lawler.  Zuber Lawler represents clients throughout the world from offices in Chicago, Los Angeles, New York and Silicon Valley.  Zuber Lawler represents clients most often on the areas of M&A and other deals; IPOs; intellectual property; regulatory work; and litigation and investigations.  Zuber Lawler’s attorneys work in languages covering 90% of the world’s population.   Mr. Zuber is the relationship partner for some 10 Fortune 500 Company clients of the firm, as well as funds and government entities. He has advised some of the most iconic companies in the world on their patent and trademark disputes, deals and globa ... (view full description)

Amanda de Freitas

CEO
Cannaceutical Canada Ltd

Amanda de Freitas is a Toronto based regulatory compliance executive and lobbyist who specializes in Canadian cannabis legislation. She is the CEO of Cannaceutical Canada Ltd, a management consulting firm that focuses on global medical cannabis supply transactions and deal development. Amanda is also President and founder of CannaBiz Solutions Company, a firm that’s primary focus is on domestic medical and adult use cannabis businesses, helping assist them with their regulatory compliance, licensing, corporate and product development strategies. Her expertise within the areas of Canadian Cannabis Regulatory Compliance and Medical Cannabis Brand Development are aligned well ... (view full description)
NETWORK OPEN
Sign In
 
Sign in with LinkedIn
Contact Information
INFORMATION MANAGEMENT NETWORK
1120 Avenue of the Americas, 6th Floor
New York, NY 10036 USA


Phone: +1 (212) 901-0506
(8:30 AM - 5:30 PM Eastern Time / Monday-Friday)

E-mail: mail@imn.org


Event Contacts for IC3 - The 2nd Institutional Capital & Cannabis Conference (East)

TERMS AND CONDITIONS OF USE

Below are the terms and conditions governing your use of EIMN, LLC ("IMN") this website and any products or services connected therewith. By using the website or services connected with the website, you acknowledge and agree to the following:

*Your Obligations. You represent and warrant that you have the capacity to agree to these Terms and you are at least eighteen (18) years of age. To the extent any individual accesses a Site or uses a Service as an employee, partner, director, agent or representative ("Agent") of any legal entity which is a Subscriber, the Agent warrants that he or she has authority to agree to these Terms on behalf of the relevant legal entity.

You will procure that you and any licensed user under your subscription will: (a) comply with all applicable laws in relation to the site and services, including without limitation, laws relating to the use of Intellectual Property; (b) not use the site or the content outside the scope of permitted use and will not infringe any Intellectual Property or other rights in or relating to the site or the services or of any third party; (c) not copy, reproduce, recompile, decompile, disassemble, reverse engineer, upload, download, transmit, create derivative works from or otherwise exploit or tamper with the site or any software embodied in any site or service; (d) not prevent or restrict the use of any site or service by other authorized users nor hack into or cause damage to any server or other equipment operated by us; and (e) comply fully with these Terms.

*No IMN Warranties or Representations. IMN makes no warranty, express or implied, concerning any use of this website or any service or product provided in connection with this website. The services and products provided by IMN are provided on an "AS IS" basis. IMN disclaims any implied warranty of merchantability or fitness for a particular purpose, including any warranty for the use or the results of the use of the products or services. IMN is not responsible for correcting, maintaining or updating the data and services made available on this website.

Any material and analysis provided by or through IMN or this website is not a recommendation that must be followed or an offer, or solicitation of an offer to buy or sell any financial product; IMN does not recommend that you enter into a particular transaction or represent that any product or service described on this website is suitable for you or your company. Nor is any information displayed here promoting any particular financial product, service or trading strategy in any jurisdiction where such an offer or solicitation, or trading strategy may be prohibited. As all prudent investors know, some transactions, including but without limitation, those involving high-yield securities, give rise to substantial risk and any investment decision you may make is your own. You should not enter into any transactions unless you have fully understood all such risks and have independently determined that such transactions are appropriate for you. Any discussion of the risks contained herein with respect to any product should not be considered to be a disclosure of all risks or complete discussion of the risks mentioned.

*Restricted Use. As a user of this website, you are not permitted to display, modify, copy, print or otherwise use the information made available to you here only for your own use. You are not permitted to publish, transmit, or otherwise make this information available in any format to any third party without the prior express written consent of IMN. You also are not permitted to change or remove any copyright (©), trademark (®, SM, TM) any other notices displayed with the information. IMN can modify the information at any time and for any reason at its sole discretion. Unless expressly stated otherwise herein, no rights are granted to you regarding the information on this website from IMN or any other source, including third party providers of information for this website, which shall under no circumstances be liable to you in any way.

*IMN Monitoring. Your use of the products and services on this Web site may be monitored by IMN in any lawful manner, and that the resulting information may be used by IMN for its internal business purposes or in accordance with the rules of any applicable regulatory or self-regulatory organization.

*Website or Internet failure. IMN shall have no liability, contingent or otherwise, to you or to third parties, or any responsibility whatsoever, for the failure of any connection or communication service to provide or maintain your access to this service, or for any interruption or disruption of such access or any erroneous communication between IMN and you. IMN also does not warrant or represent that the website shall be completely secure, specifically including without limitation, that no unauthorized person shall intercept or access information transmitted by you.

*Website Access. Access to this website is restricted by password and only authorized IMN registrants may use the website. Any unauthorized access shall be the responsibility of the Registrant and his or her company and IMN shall not be liable for any damages arising out of such unauthorized access. You agree to: (1) Keep your password confidential; (2) prohibit others from using your account; (3) refrain from using other Users’ accounts; (4) refrain from selling, trading, or otherwise transferring your account to another party; and (5) refrain from charging anyone for access to any portion of DirectConnect, or any information arising therefrom. You are also responsible for anything that happens through your account unless you can demonstrate that your account was accessed without your knowledge or fault.

*User Communication. To the extent permitted while using DirectConnect, you can use and participate in groups, free to post and delete comment on the website. You are solely responsible for your interactions with other users. IMN may limit the number of connections you may have to other users and may at its sole discretion prohibit you from contacting other users through use of the Services or otherwise limit your use of the Services.

If you violate this Agreement while posting, that content may be removed without further notice or the rights of others posting here. Nothing you post here is confidential or proprietary and you are cautioned that other posters or viewers may use any information posted here. By posting here you agree that IMN is not responsible for the misappropriation or misuse of any information posted on this website.

*Privacy. Any submissions, including private personal information, like names, addresses and so on, are voluntary and you waive any and all rights you have to the protection of that information. By submitting ideas, suggestions, documents or other matter ("Submissions"), you agree that: (a) the Submissions are not confidential or proprietary information; (b) IMN has no obligation to keep the submissions confidential; (c) IMN can use or disclose the Submissions for any purpose, in any way, in any media worldwide; (d) if asked, you will irrevocably assign to IMN all rights to your Submissions; and (f) you are not entitled to any compensation of any kind from IMN under any circumstances.

*Content by Becoming a User of DirectConnect: As part of obtaining registration access to DirectConnect, unless you opt out, you may receive invitations to network from other conference attendees. We may also send you emails to keep you updated on developments in the site and services. Your registration for and/or subscription to such an email service and your use of the content received through these email services will be subject to these terms. You can unsubscribe to our email service by changing your email preferences on the website.

*License. If you comply with all your obligations under this Agreement, IMN grants you a limited, revocable, nonexclusive license and right to access the Services, through a generally available web browser, mobile device or application view information and use the web pages and in accordance with this Agreement for your use only. Any other use of DirectConnect is strictly prohibited. All rights not expressly granted in this Agreement, including, without limitation, title, ownership, intellectual property rights, and all other rights are retained by IMN.

*Anti-Hacking. You expressly agree not to use or attempt to use any "virus," "spyware," "malware," "adware," "Trojan horse" "deep-link," "scraper," "bot," "spider," "data-mining," "computer code" or any other automated device, program, tool, algorithm, process, or methodology or manual process having similar processes or functionality, to access, acquire, copy, or monitor any portion of this website or content. You also agree not to obtain or attempt to obtain through any means any materials or information on the website that have not been intentionally made available either by their public display on the Web Site or through their accessibility by a visible link or portal. You further agree not to violate the security of the website or attempt to gain unauthorized access to the website, data, materials, information, computer systems or networks connected to any server, through hacking, password mining or any other method.

*No Linkage. You expressly agree not to link or attempt to link to this website or the web pages contained herein.

*Third Party Information. Some of the information you access here is the property of third parties, made available here with the express permission of those third parties. IMN is not responsible for the content of any third party information provided on this website. You are cautioned that any further use of that information by you may be subject to the rights of those third parties and you may be required to obtain a license to use any such information. Failure to obtain third party permission may be a violation of federal law. You should contact the third party provider of the information to ascertain the requirements for using the information.

*Copyright and Trademarks. The layout of the website pages, graphics and pictures used and the collection of individual contributions are protected by copyright. All copyrights belong either to IMN, the third-party content providers or both. Either IMN or the third-party content providers own all trademarks and service marks depicted here.

*Indemnification. You agree to indemnify hold harmless and defend IMN, including our employees, officers, agents and contractors and our related entities and their employees, officers, partners, agents and contractors ("Indemnified") and continue to keep the Indemnified indemnified from and against any actions, proceedings, claims, demands, costs (on a full indemnity basis including, without limitation, reasonable legal and accounting fees) brought or made against the Indemnified by any person arising in connection with your use of the Website or content, or a breach of your representations and warranties in the Terms and Conditions of Use or this Agreement, or your violation of any of the Terms and Conditions of Use or this Agreement or any other activity in which you engage on or through, and from and against any damage, loss(whether personal or property, and whether direct or consequential, including without limitation consequential financial loss), cost or expense suffered or incurred by any Indemnified as a direct or indirect consequence thereof.

*Changes in Terms and Conditions. IMN may at any time revise the terms and conditions by which you may access the website or use IMN products or services. By using this website and IMN products and services, you agree to be bound by any such revisions and should therefore periodically visit this page to determine the then current version of this document.

*Limitation of Liability. Neither we, nor any of our suppliers, officers, employees, partners, affiliates, subsidiaries, successors and assigns, agents or representatives (our "Representatives") will be liable to you for:

(a) any incidental, punitive, indirect, special or consequential damage, loss or expenses, including but not limited to any loss of business, contracts, revenue, or profits, any business interruption, security breach, loss of data, loss of goodwill or reputation or other pecuniary loss suffered by you, even if we or any of our Representatives have been advised of their possible existence; nor? (b) any direct damage loss or expenses arising from loss of customers, loss of profits, loss of anticipated profits or loss of savings.

*Termination. You may terminate this Agreement, for any or no reason, at any time, when IMN receives notice from you. IMN may terminate the Agreement and your account for any reason or no reason, at any time, with or without notice. This cancellation shall be effective immediately or as may be specified in the notice and may include disabling your current and future access to DirectConnect. IMN may also suspend or terminate this Agreement if you invite other users with whom you do not know to connect; abuse the any DirectConnect messaging services; creating multiple or false profiles; infringe on any intellectual property rights, violating any provisions in this Agreement, disparage IMN or its executives, Board members, affiliates, staff or other related entities or persons, or exhibit any other behavior that IMN, in its sole discretion, deems contrary to the purpose of the website.

*No Waiver. Failure by either party to exercise any right or remedy under these Terms does not constitute a waiver of that right or remedy.

*Entire Agreement. These terms (including any terms incorporated by reference in these terms), constitute the entire agreement between you and us with respect to your access to and use of the website or receipt of any service and supersede all prior agreements, negotiations and discussions between you and us relating to the same.

*Law and Jurisdiction. Where you visit, register and/or subscribe to a this site or related service (as indicated on this website or otherwise notified to you), these terms (and any dispute or claim arising out of or in connection with these terms, including non-contractual disputes or claims), to the maximum extent permissible under the law of the territory that you are located in, will be governed by the laws of the State of New York. Any action to enforce these terms shall be brought in a federal court or a state court located in the state of New York, county of New York, and you agree to submit yourself to the personal jurisdiction of those courts in any such action.

*Force Majeure. We shall not be deemed to be in breach of these Terms by reason of any delay in performing, or any failure to perform any service or our obligations in relation to these Terms, if the delay or failure was due to any cause beyond our reasonable control, including but not limited to acts of God, explosions, floods, fire or accident, war or threat of war, terrorism or threat of terrorism, sabotage, civil disturbance, epidemics, prohibitions or measures of any kind on the part of any governmental, parliamentary or local authority, import or export regulations or embargoes, or industrial actions or trade disputes (whether involving our employees or of third parties).

*Severability. If any provision of these Terms is found to be wholly or partially invalid, void or unenforceable by any court having competent jurisdiction or by virtue of any legislation or any other reason, that provision shall be invalid, void or unenforceable to that extent only and no further and the validity and enforceability of the remaining provisions of these Terms shall not be affected.

*Notices. Any notice given pursuant to these Terms shall be made by email or first class post, in the case of you, to the address provided on your registration form and, in the case of us, to the address posted on the website or otherwise notified to you in relation to any relevant service. Any such notice shall be deemed to have arrived if sent by post within three (3) days of posting and if sent by email at the time of transmission.
Information Management Network - Privacy Notice

Introduction - Who we are

Euromoney Institutional Investor PLC (“Euromoney”, “we”, “us” or “our”) is an international business-information group covering asset management, price discovery, data and market intelligence, and banking and finance. The group also runs an extensive portfolio of events for the telecoms, financial and commodities markets.

For a full list of our brands and group companies, please click on this link. Euromoney and its group companies are committed to respecting the privacy of every person who visits, registers with or subscribes to our websites, publications, events and other products or services.

Euromoney is the primary data controller of personal data collected through this website or that we may collect in different ways as described in this Privacy Notice. If you are contacted by our other group companies, they will also be controllers of your personal data. This means that they are responsible for how your personal data is used, just as we are. You may contact any of these companies directly, or you can contact Euromoney by emailing dataprotectionofficer@euromoneyplc.com or writing to the Data Protection Officer at Euromoney Institutional Investor PLC, 8 Bouverie Street, London EC4Y 8AX, United Kingdom.

This Privacy Notice was updated on 23 May 2018

Our Approach to Your Privacy

This Privacy Notice outlines the information we may collect about you in relation to your use of our products and services (“personal data”). It also explains the legal rights that you have in relation to your data and how you may exercise these rights.

Some of our group companies may collect and use personal data for different purposes; those companies have their own websites and privacy notices.

We will process your data for the following lawful purposes: with your consent; to fulfil our obligations to you; and where there is a legitimate interest to do so.

When possible, we rely on your consent to use your data for the purposes described in this Privacy Notice. We also process personal data to fulfil our contractual obligations to you, for example, when you register for any of our services, subscribe to a publication, sign-up for an event or purchase a product from us, we will need to process some of your personal data. This will also include details of the person/people responsible for payment (if different).

We may determine that processing your personal data serves both of our legitimate interests. This is the case in relation to many of our research, customer survey, sales, marketing and advertising activities described in this Privacy Notice. These activities allow us to better understand your requirements, which in turn enables us to provide you with a better service. We review the bases for our processing decisions carefully and you can object to these activities at any time (see the “Your Rights” section of this Privacy Notice).

What Personal Data We Collect & Why

Our primary goal in collecting personal data from you is to give you a relevant customised experience of our products and services.

  • Registration, Free Trials & Subscriptions

    When you register with our website and/or sign up for a free trial of our products or services, we may ask you to provide your name, address, email address and telephone number, and details relevant to your occupation or employer.

    If you subscribe to one of our products or services, we will also ask for payment details. Credit/debit card payments are processed using a third party supplier and we do not retain the credit card data (see the Third Party Sites of this Privacy Notice). Address details may be shared with third party service providers engaged by us for order fulfilment, delivery and payment collection. This personal data is used by us to complete subscription requests.

  • Events & Conferences

    If you have registered for an event through a group website we may collect personal data including: name, job title, company, address, telephone number and email.

    This information is necessary so that we can complete your registration for the event and provide you with relevant event materials.

    We may also provide delegate details (e.g. name, email) to event sponsors who, subject to your consent, may contact you for their own advertising and marketing purposes.

  • Advertising & Marketing

    We use the personal data you provide us and which we collect from you to inform you about similar products and services which we provide. We may send you marketing communications that are sponsored by our partners and which are targeted to your interests based on information you have provided us such as job title, employer and/or industry. If you have consented to receive information from other Euromoney group companies, we may share your personal data with these companies so that they can fulfil your request to receive marketing materials in accordance with your preferences. We will not share your personal data with any third parties for their own marketing purposes unless you have provided your consent.

    Each of the Euromoney group companies that may contact you is a data controller in relation to the personal data that you have agreed to share with them. If you have any questions or concerns, you may contact the individual company, or us – using the contact details set out in the “Who We Are” section.

    You can opt out from receiving such materials at any time.

    The personal data we may use for advertising and marketing purposes includes your name, email address, job title, phone number, company name/employer, geo location, postal address and data collected using cookies and other similar technology (Please read our separate Cookies Policy to find out more about which cookies we use, how they work and how you can control your cookie options).

    Marketing materials are sent electronically, by post and we may occasionally call you.

  • Online Targeted Advertising

    We use targeted advertising on our websites to display advertisements that are relevant to what we believe are your interests. In order to deliver relevant advertisements, we use third parties to deliver cookies that collect information about your IP address and how you interact with our sites (e.g. browsing information, which articles you have read etc.). This data is used by the third parties to determine which advertisements may be of interest to you.

    We may also share your personal data with third parties to deliver targeted advertising to you on other websites (e.g. Twitter Tailored Audiences or Facebook Custom Audiences). This could include your email address, cookie data, and information obtained from third parties. Third party cookies may also be used to enable us to target advertisements to you on other websites that you visit.

  • Lead Generation and Scoring

    We occasionally use the services of trusted third parties in order to ensure that the personal data we use for advertising and marketing purposes is accurate and up-to-date. To do this, we transfer personal data of individual leads (such as name, email, job title, location and phone number) to these third parties who conduct research to verify the data – primarily against public information.

    We also use algorithmic software technology to help us improve the quality and relevance of marketing activities. The personal data analysed by the software includes email address, phone number, job title, address, purchase history and account information. This allows us to provide meaningful offers that are relevant to your specific profile.

  • Surveys, Market Research & Customer Feedback

    We want to understand the needs of our readers and customers. We may therefore use the information you provide us – including your name and contact details – to contact you to request your feedback, or to participate in our customer and market research.

  • Public forums, message boards and blogs

    Some of the pages on our group websites may include message boards, blogs or other facilities for generating content from users. Any information that is disclosed in these areas becomes public information and you should always be careful when deciding to post any personal data. User generated content is also subject to our site Terms & Conditions.

  • Business or Asset Sale

    If we sell a business or assets we may need to disclose your personal data to the prospective buyer of such business or assets.

    If Euromoney, or any of our group companies is sold or sells our assets or is acquired by a third party, then personal data about our customers will be acquired by that third party. A transfer of your personal data in these circumstances would be necessary so that the services you have contracted for can still be delivered, or so that you can continue to enjoy the benefits of our free products and services. You will receive notice if a new controller assumes responsibility for your personal data.

  • Additional Third Party Disclosures

    We may disclose your personal data to other third parties in the following situations:

    • To third party partners who help us by providing services such as technology, marketing, advisory or other services. These third parties only receive encrypted data and may only process personal data to provide those services to us.
    • Where we are required by law or regulation to do so. In each case we will seek, where practicable, to minimise the amount of data that is disclosed.
    • If required to protect the rights and interests of other users and/or Euromoney and its affiliates (including our employees, agents and contractors), or as otherwise set out in our Terms & Conditions. This may include exchanging information with other companies and organisations for the purposes of fraud protection.
  • Email Tracking

    We may include small pixel tags (small image files) within the emails we send you in order to determine whether our emails are opened and/or whether the hyperlinks inside our emails are clicked through. We may also collect browser, location and the device used to engage with our email communications. This information allows us to better understand whether we are meeting our users’ needs and how we can improve our communications. No other information is collected. You can opt out of receiving our direct marketing emails either by following the instructions in each email, or by contacting us (see the “Who We Are” section of this Privacy Notice).

International Transfers

Some of the Euromoney group companies are based outside the European Economic Area (EEA). If you have consented to being contacted by our group companies, then the transfer of your personal data will be made according to the terms of an international data sharing agreement that contains obligations approved by European data protection regulators. Any of our group companies that receive your personal data will be co-controllers of that data, which means they may determine how they process your personal data – although they may only use it for the purposes for which it was shared, unless you are informed of new or additional processing activities.

We may also transfer personal data to third party service providers as described in this Privacy Notice which are located outside the EEA. Where we conduct these transfers, we take all steps necessary to ensure that your data is treated securely and in accordance with applicable privacy legislation, either by only sending your personal data to jurisdictions that provide an adequate degree of legal protection for your data or by imposing approved contractual terms on these third parties.

Retention Periods

We have a data retention policy that ensures we don’t use or store your personal data for longer than necessary. We consider the following issues to determine retention periods:

  • Guidance from the UK Information Commissioner or other regulatory agency, or industry best practice recommendations;
  • The business rationale for collection and expiry of the purpose for which personal data was collected;
  • Our ongoing ability to ensure the accuracy of the data; and
  • Legal and regulatory requirements.

We may occasionally need to keep personal data for either shorter or longer periods than specified in our retention policy. In such circumstances, application of the retention period to the data will be temporarily suspended. The suspension of an applicable retention period will be carried out in a manner that respects the rights and interests of all persons concerned.

How You Can Set Your Data & Privacy Preferences

You can use our Preference Centre to select the topics that are of interest to you so that we can send you publications and information about our products and services that are especially relevant to you. You can also choose the channels we use to contact you (email, phone, post, etc.) and can also opt-out of receiving marketing communications.

Your Rights

You have certain rights in relation to your personal data which include the following:

  • Access & Portability

    You may request access to any personal data of yours for which Euromoney is responsible as controller. Unless there are legal or regulatory reasons for not doing so, we will confirm whether we process any of your personal data and if we do, we will provide you with the following information: the purposes of the processing, the categories of personal data, any recipients of your personal data, the applicable retention period and the data source. Copies of your personal data will be made available to you in a structured, machine-readable format.

    You may also request that we transfer the personal data that you have submitted to us, to another controller, where it is technically feasible for us to do so.

    If you have consented to our processing of your personal data, or if we are processing your personal data in order to fulfil our contractual obligations to you, then you can submit a request that we transfer your personal data to another data controller.

  • Rectification, Restriction, Objection

    You have the right to request that Euromoney rectify any errors in the personal data that we process. In some circumstances, you may also be able to ask for the erasure of personal data, and/or request that the processing of your personal data be restricted. You may also object to the processing of your personal data for sales or marketing purposes.

  • How to Exercise Your Rights

    To exercise any of these rights, please contact us by post or email at the following addresses:

    Euromoney Institutional Investor PLC
    8 Bouverie Street
    London, EC4Y 8AX
    United Kingdom

    Email: dataprotectionofficer@euromoneyplc.com

    Web form: Complete Subject Data Request Form

    We may need to check your identity prior to processing a request.

    Euromoney will do our best to respond to any questions and address any of your concerns. You are also able to register any complaints regarding the processing of your personal data directly with the UK Information Commissioner.

Protecting Your Data

Euromoney is committed to keeping your personal data secure and we will take appropriate technical and organisational measures to protect your personal data from loss, unauthorised use, disclosure or destruction. Although we do our best to protect your personal data, we cannot guarantee that any transmission of data is without risk. We have therefore implemented information security policies and rules, staff training on information security, and technical measures to ensure the integrity of data that we have under our control.

All our employees, contractors and data processors (i.e. those third parties that process personal data on our behalf) are required to keep such data confidential and not to use it for any purpose other than the performance of services we have requested.

Third Party Sites

Our site may contain links to other websites – including, for example, providers of payment processing services. Euromoney is not responsible for the privacy and data collection practices of third party sites and we therefore recommend that you review the privacy policies and terms of service of each site you visit.

email already exists, please use "Forgot Password" page to reset a password for an existing account.
(Click "Reset Password" button below and email with password reset instruction will be emailed to you.)

Reset Password